PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 68 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

4 July 2024

  1. (diff | hist) 11:48 Talk:Flourishglobal Peptide Biotech 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  2. (diff | hist) 11:48 Talk:GL Biochem (Shanghai) 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  3. (diff | hist) 11:48 Talk:Guangzhou JEEP Biotechnology 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  4. (diff | hist) 11:48 Talk:Hubei Jianxiang Bioscience 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  5. (diff | hist) 11:48 Talk:Hunan Aslsen Technology 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  6. (diff | hist) 11:48 Talk:Nantong Guangyuan Chemical 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  7. (diff | hist) 11:48 Talk:Qingdao Saber Technology Pharmaceutical 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  8. (diff | hist) 11:48 Talk:Qingdao Sigma Chemical 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  9. (diff | hist) 11:48 Talk:Sangon Biotech 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  10. (diff | hist) 11:48 Talk:Shanghai ERP Biotechnology 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  11. (diff | hist) 11:48 Talk:Shanghai Sigma-Audley New Material Technology 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  12. (diff | hist) 11:48 Talk:Shanghai Wibson Biotechnology 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  13. (diff | hist) 11:48 Talk:Tianjin Finder Chemical 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  14. (diff | hist) 11:48 Talk:Wuhan Wansheng Biotechnology 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  15. (diff | hist) 11:48 Talk:WuXi TIDES 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  16. (diff | hist) 11:48 Talk:Xi'an Mokemei Biotechnology 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  17. (diff | hist) 11:48 Talk:Zhuhai Kerui Biotechnology 885 +220 CoI_Corin (talk | contribs) /* Standing note: what this article may not contain */ reply
  18. (diff | hist) 09:12 Talk:Bachem Holding (Suzhou) 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  19. (diff | hist) 09:12 Talk:ChinaPeptides 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  20. (diff | hist) 09:12 Talk:Chinese Peptide Company 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  21. (diff | hist) 09:12 Talk:Flourishglobal Peptide Biotech 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  22. (diff | hist) 09:12 Talk:GL Biochem (Shanghai) 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  23. (diff | hist) 09:12 Talk:Guangzhou JEEP Biotechnology 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  24. (diff | hist) 09:12 Talk:Hubei Jianxiang Bioscience 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  25. (diff | hist) 09:12 Talk:Hunan Aslsen Technology 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  26. (diff | hist) 09:12 Talk:Nantong Guangyuan Chemical 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  27. (diff | hist) 09:12 Talk:Qingdao Saber Technology Pharmaceutical 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  28. (diff | hist) 09:12 Talk:Qingdao Sigma Chemical 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  29. (diff | hist) 09:12 Talk:Sangon Biotech 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  30. (diff | hist) 09:12 Talk:Shanghai ERP Biotechnology 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  31. (diff | hist) 09:12 Talk:Shanghai Sigma-Audley New Material Technology 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  32. (diff | hist) 09:12 Talk:Shanghai Wibson Biotechnology 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  33. (diff | hist) 09:12 Talk:Tianjin Finder Chemical 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  34. (diff | hist) 09:12 Talk:Wuhan Wansheng Biotechnology 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  35. (diff | hist) 09:12 Talk:WuXi TIDES 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  36. (diff | hist) 09:12 Talk:Xi'an Mokemei Biotechnology 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  37. (diff | hist) 09:12 Talk:Zhuhai Kerui Biotechnology 674 +382 NPOV_Nadia (talk | contribs) /* Standing note: what this article may not contain */ new section
  38. (diff | hist) m b 09:06 GLP-1 receptor agonist 2,788 +1,146 CiteBot (talk | contribs) bot: repair redlinked category [rollback]
  39. (diff | hist) 07:07 Cold chain 5,128 +1,480 CrudePeptidePearl (talk | contribs) expand §Distribution outside regulated channels [rollback]
  40. (diff | hist) 03:48 Glucose-dependent insulinotropic polypeptide 2,551 +793 GIP_Genoveva (talk | contribs) the half-life given was for the intact peptide; label it [rollback]

3 July 2024

  1. (diff | hist) 19:48 Third-party testing 1,906 +467 PrepHPLC_Pia (talk | contribs) space between number and unit per PP:MOS [rollback]
  2. (diff | hist) 18:16 Glucagon-like peptide-1 3,005 +1,519 Peptide_Pete (talk | contribs) give the fasting and postprandial concentrations with the assay named [rollback]
  3. (diff | hist) 17:08 Solid-phase peptide synthesis 1,893 ±0 ForestPlotFinn (talk | contribs) expand §Support and linker [rollback]
  4. (diff | hist) 10:47 Peptide 1,981 ±0 EndotoxinEd (talk | contribs) rm the vendor-specific packaging detail; not general enough for the article [rollback]
  5. (diff | hist) 03:10 Third-party testing 1,439 ±0 GradientGus (talk | contribs) convert a hard-coded date to the house format [rollback]

2 July 2024

  1. (diff | hist) N 23:06 Reverse-phase HPLC 1,347 +1,347 TFA_Counterion (talk | contribs) start article on the analytical method
  2. (diff | hist) m 21:35 Adverse effects of GLP-1 receptor agonists 1,312 ±0 Chromatokid (talk | contribs) expand §Body composition and other effects [rollback]
  3. (diff | hist) 15:10 Reconstitution of lyophilised peptides 2,071 ±0 AnalyticalAnnie (talk | contribs) add the dead-space volume to the worked example [rollback]
  4. (diff | hist) 08:50 GLP-1 receptor 2,831 ±0 BetaCellBoyd (talk | contribs) clarify that the incretin effect is defined by the oral–intravenous comparison [rollback]
  5. (diff | hist) 06:33 GL Biochem (Shanghai) 1,798 ±0 SecondarySrc_Seb (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]
  6. (diff | hist) m 03:37 Tirzepatide 2,181 ±0 IcodecIndra (talk | contribs) expand §Adverse effects and tolerability [rollback]
  7. (diff | hist) 01:44 Wuhan Wansheng Biotechnology 1,758 ±0 WeaselWordWim (talk | contribs) rm the price; supplier articles carry no price per PP:VN [rollback]

1 July 2024

  1. (diff | hist) N 09:00 Retatrutide 2,390 +2,390 GastroparesisGwen (talk | contribs) create article — compound stub

30 June 2024

  1. (diff | hist) 19:05 Mass spectrometry 2,090 +732 ShortageShona (talk | contribs) close an unbalanced quotation mark [rollback]
  2. (diff | hist) N 09:00 Adverse effects of GLP-1 receptor agonists 1,312 +1,312 ChainCustodyChad (talk | contribs) create article — adverse-effect stub
  3. (diff | hist) N 02:39 Mass spectrometry 1,358 +1,358 ImportRecordIna (talk | contribs) start article on the analytical method

29 June 2024

  1. (diff | hist) 11:22 High-performance liquid chromatography 2,129 ±0 Retention_Time_Rae (talk | contribs) typo [rollback]
  2. (diff | hist) 08:15 Semaglutide 2,607 +30 SemaglutideSasha (talk | contribs) add see also to the amylin analogue [rollback]

28 June 2024

  1. (diff | hist) m 15:36 Peptide synthesis 2,036 ±0 AAA_Analyst (talk | contribs) rm the blanket claim that excursions are harmless [rollback]
  2. (diff | hist) N 09:00 STEP trial programme 1,299 +1,299 EndpointEnid (talk | contribs) start article; endpoints and registration only
  3. (diff | hist) N 09:00 Wuhan Wansheng Biotechnology 1,758 +1,758 Ref_Desk_Ron (talk | contribs) create organisation article per PP:VN
  4. (diff | hist) 02:51 Incretin effect 1,841 ±0 AmylinAmos (talk | contribs) the article treated a rodent finding as human physiology; corrected [rollback]

27 June 2024

  1. (diff | hist) m b 20:38 Tirzepatide 2,181 +793 CategoryBot (talk | contribs) bot: repair redlinked category [rollback]

26 June 2024

  1. (diff | hist) m 23:26 Cold chain 3,648 ±0 CRP_Cormac (talk | contribs) correct the freezer temperature range given for long-term storage [rollback]
  2. (diff | hist) N 22:51 Third-party testing 1,439 +1,439 BatchNumberBede (talk | contribs) start article on the testing subject
  3. (diff | hist) N 09:00 Peptide synthesis 2,036 +2,036 MolarMassMaeve (talk | contribs) new article: supply and handling, expansion welcome
  4. (diff | hist) 04:34 Dipeptidyl peptidase-4 2,323 ±0 Chromatokid (talk | contribs) expand §Evading the enzyme [rollback]

25 June 2024

  1. (diff | hist) m 22:31 Solid-phase peptide synthesis 1,893 +542 BlankVialBo (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  2. (diff | hist) N 06:30 Solid-phase peptide synthesis 1,351 +1,351 SupplyWatchSuri (talk | contribs) create article — process stub

24 June 2024

  1. (diff | hist) m b 13:15 Semaglutide 2,577 ±0 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  2. (diff | hist) m 11:53 Glucose-dependent insulinotropic polypeptide 1,758 ±0 AAA_Analyst (talk | contribs) convert the receptor-distribution list to a table [rollback]
  3. (diff | hist) 00:57 GLP-1 receptor 2,831 ±0 SVG_Solomon (talk | contribs) space between number and unit per PP:MOS [rollback]

23 June 2024

  1. (diff | hist) m 20:27 Reconstitution of lyophilised peptides 2,071 +584 DrTitration (talk | contribs) state the syringe graduation the unit figure assumes [rollback]

22 June 2024

  1. (diff | hist) m 20:38 GL Biochem (Shanghai) 1,798 ±0 NAION_Noel (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  2. (diff | hist) N 09:00 Dipeptidyl peptidase-4 2,323 +2,323 ProglucagonPia (talk | contribs) create article — physiology stub
  3. (diff | hist) 07:10 Glucagon-like peptide-1 1,486 ±0 BPC_Bramwell (talk | contribs) give the magnitude of the incretin effect as a percentage of the insulin response [rollback]
  4. (diff | hist) 03:48 High-performance liquid chromatography 2,129 ±0 PeakShapePol (talk | contribs) add the figure for the chromatogram and caption its axes [rollback]
  5. (diff | hist) 01:55 Peptide 1,981 ±0 SchematicScout (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  6. (diff | hist) m 00:37 Glucagon-like peptide-1 1,486 ±0 NPOV_Nadia (talk | contribs) the glucose-dependence of the insulinotropic effect deserves its own sentence [rollback]

21 June 2024

  1. (diff | hist) N 22:14 GL Biochem (Shanghai) 1,798 +1,798 CRP_Cormac (talk | contribs) start organisation article — registry facts and product scope only
  2. (diff | hist) 20:29 GLP-1 receptor agonist 1,642 ±0 TB500_Tarquin (talk | contribs) add the peptide length to the infobox [rollback]
  3. (diff | hist) m 07:52 GLP-1 receptor agonist 1,642 ±0 CuriousCallum (talk | contribs) expand §Mechanism [rollback]
  4. (diff | hist) N 06:11 Reconstitution of lyophilised peptides 1,487 +1,487 COA_Colwyn (talk | contribs) new article: dosing and handling, expansion welcome
  5. (diff | hist) 00:40 Incretin effect 1,841 ±0 AnalyticalAnnie (talk | contribs) attribute the gastric-emptying effect to the study that measured it [rollback]

20 June 2024

  1. (diff | hist) m 19:11 Cold chain 3,648 +656 CommaCarys (talk | contribs) add the cross-link to the temperature-excursion article [rollback]

19 June 2024

  1. (diff | hist) N 09:00 Cold chain 2,992 +2,992 LedgerLysander (talk | contribs) create article — process stub
  2. (diff | hist) N 09:00 GLP-1 receptor 2,831 +2,831 MicrodoseMagnus (talk | contribs) start article on the hormone

18 June 2024

  1. (diff | hist) N 09:00 High-performance liquid chromatography 2,129 +2,129 MassSpecMarv (talk | contribs) new article: analytical method, expansion welcome
  2. (diff | hist) N 00:50 Glucose-dependent insulinotropic polypeptide 1,758 +1,758 EmptyingElke (talk | contribs) new article: incretin physiology, expansion welcome

17 June 2024

  1. (diff | hist) N 17:26 GLP-1 receptor agonist 1,642 +1,642 BlindSampleBrid (talk | contribs) create article — compound stub
  2. (diff | hist) N 12:42 Glucagon-like peptide-1 1,486 +1,486 LCellLeif (talk | contribs) start article on the hormone

16 June 2024

  1. (diff | hist) m 11:07 Tirzepatide 1,388 ±0 DulaglutideDug (talk | contribs) add the excipient list from the labelling [rollback]

15 June 2024

  1. (diff | hist) N 12:42 Tirzepatide 1,388 +1,388 MolarMassMaeve (talk | contribs) start article on the compound
  2. (diff | hist) m 03:11 Peptide 1,981 ±0 Chromatokid (talk | contribs) correct the humidity figure — relative humidity needs its temperature [rollback]

14 June 2024

  1. (diff | hist) m 17:03 Semaglutide 2,577 ±0 MazdutideMads (talk | contribs) attribute the potency comparison to the head-to-head trial rather than to two separate ones [rollback]

12 June 2024

  1. (diff | hist) N 17:48 Semaglutide 2,577 +2,577 CrudePeptidePearl (talk | contribs) create article — compound stub
  2. (diff | hist) N 09:00 Incretin effect 1,841 +1,841 BatchNumberBede (talk | contribs) new article: incretin physiology, expansion welcome

11 June 2024

  1. (diff | hist) N 09:09 Peptide 1,981 +1,981 FreightFenna (talk | contribs) new article: supply and handling, expansion welcome